Alzheimer's Drug Shows Promise for Sickle Cell Patients

A safe, affordable medication already used for Alzheimer's disease could become a game-changer for people with sickle cell anemia, especially in resource-limited areas. Early clinical trials show memantine reduces hospitalizations and painful episodes while improving quality of life.